{
  "id": "clinical#screening_cues_a2e8a47d",
  "content": "The term neuroleptic is becoming outdated because it highlights the\npropensity of antipsychotic medications to cause abnormal movements,\nand it is being replaced with the term antipsychotic in many contexts.\nNevertheless, the term neuroleptic remains appropriate in this context.\nAlthough newer antipsychotic medications may be less likely to cause\nsome medication-induced movement disorders, those disorders still oc-\ncur. Neuroleptic medications include so-called conventional, “typical,”\nor first-generation antipsychotic agents (e.g., chlorpromazine, haloperi-\ndol, fluphenazine); “atypical” or second-generation antipsychotic\nagents (e.g., clozapine, risperidone, olanzapine, quetiapine); certain do-\npamine receptor–blocking drugs used in the treatment of symptoms\nsuch as nausea and gastroparesis (e.g., prochlorperazine, promethazine,\ntrimethobenzamide, thiethylperazine, metoclopramide); and amoxa-\npine, which is marketed as an antidepressant.\n345\n346 Medication-Induced Movement Disorders\nNeuroleptic-Induced Parkinsonism\nOther Medication-Induced Parkinsonism\n332.1 (G21.11) Neuroleptic-Induced Parkinsonism\n332.1 (G21.19) Other Medication-Induced Parkinsonism\nParkinsonian tremor, muscular rigidity, akinesia (i.e., loss of move-\nment or difficulty initiating movement), or bradykinesia (i.e., slow-\ning movement) developing within a few weeks of starting or raising\nthe dosage of a medication (e.g., a neuroleptic) or after reducing the\ndosage of a medication used to treat extrapyramidal symptoms.\nNeuroleptic Malignant Syndrome\n333.92 (G21.0) Neuroleptic Malignant Syndrome\nAlthough neuroleptic malignant syndrome is easily recognized in its",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "emotions",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues The term neuroleptic is becoming outdated because it highlights the\npropensity of antipsychotic medications to cause abnormal movements,\nand it is being replaced with the term antipsychotic in many contexts.\nNevertheless, the term neuroleptic remains appropriate in this context.\nAlthough newer antipsychotic medications may be less likely to cause\nsome medication-induced movement disorders, those disorders still oc-\ncur. Neuroleptic medications include so-called conventional, “typical,”\nor first-generation antipsychotic agents (e.g., chlorpromazine, haloperi-\ndol, fluphenazine); “atypical” or second-generation antipsychotic\nagents (e.g., clozapine, risperidone, olanzapine, quetiapine); certain do-\npamine receptor–blocking drugs used in the treatment of symptoms\nsuch as nausea and gastroparesis (e.g., prochlorperazine, promethazine,\ntrimethobenzamide, thiethylperazine, metoclopramide); and amoxa-\npine, which is marketed as an antidepressant.\n345\n346 Medication-Induced Movement Disorders\nNeuroleptic-Induced Parkinsonism\nOther Medication-Induced Parkinsonism\n332.1 (G21.11) Neuroleptic-Induced Parkinsonism\n332.1 (G21.19) Other Medication-Induced Parkinsonism\nParkinsonian tremor, muscular rigidity, akinesia (i.e., loss of move-\nment or difficulty initiating movement), or bradykinesia (i.e., slow-\ning movement) developing within a few weeks of starting or raising\nthe dosage of a medication (e.g., a neuroleptic) or after reducing the\ndosage of a medication used to treat extrapyramidal symptoms.\nNeuroleptic Malignant Syndrome\n333.92 (G21.0) Neuroleptic Malignant Syndrome\nAlthough neuroleptic malignant syndrome is easily recognized in its The term neuroleptic is becoming outdated because it highlights the\npropensity of antipsychotic medications to cause abnormal movements,\nand it is being replaced with the term antipsychotic in many contexts. nevertheless..."
}